How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    References

    1. Clair DG, Mustapha JA, Shishehbor M H et al. (2021) PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. Journal of vascular surgery 74(5): 1626-35

    2. Schmidt A, Schreve MA, Huizing E et al. (2020) Midterm outcomes of percutaneous deep venous arterialization with a dedicated system for patients with no-option chronic limb-threatening ischemia: The ALPS multicenter study. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 27(4): 658-65

    3. Nakama T, Ichihashi S, Ogata K et al. (2022) Twelve-month clinical outcomes of percutaneous deep venous arterialization with alternative techniques and ordinary endovascular therapy devices for patients with chronic limb-threatening ischemia: results of the DEPARTURE Japan study. Cardiovascular and interventional radiology 45(5): 622-32

    4. Cangiano G, Corvino F, Giurazza F et al. (2021) Percutaneous deep foot vein arterialization IVUS-guided in no-option critical limb ischemia diabetic patients. Vascular and endovascular surgery 55(1): 58-63

    5. Del Giudice C, Van Den Heuvel D, Wille J et al. (2018) Percutaneous deep venous arterialization for severe critical limb ischemia in patients with no option of revascularization: early experience from two European centers. Cardiovascular and interventional radiology 41(10): 1474-80

    6. Kum S, Tan YK, Schreve MA et al. (2017) Midterm outcomes from a pilot study of percutaneous deep vein arterialization for the treatment of no-option critical limb ischemia. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 24(5): 619-26